BSECompany Update6d ago · 12 Aug 2026, 07:50 pm

Resignation of director of Ms. Anand Anitha

Kabra Drugs Ltd · 524322

✦ AI SummaryMgmt Change

Kabra Drugs Ltd announced the resignation of Ms. Anand Anitha as Director of the Company, effective August 12, 2026, citing personal reasons.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kabra Drugs Ltd - 524322 - Announcement under Regulation 30 (LODR)-Resignation of Director

Attachments (1)

📄

d378683c-fabb-42f8-9eac-eb75f7f43bb5.pdf

pdf

Download →
View document text
Date: 12th August 2026 BSE Limited Phiroze Jeejeebhoy Towers 21st Floor, Dalal Street Mumbai – 400 001 BSE Scrip Code: 524322 Subject: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 (‘Listing Regulations’) relating to Appointment & Resignation of Director Dear Sir/Madam, With reference to the captioned subject and pursuant to the provisions of Regulation 30 and other applicable regulations of the Listing Regulations, please be informed that based on the recommendation of the Nomination and Remuneration Committee and Audit Committee of the Company, the Board of Directors at their meeting held today, i.e., 12th August 2026 have considered and approved taken note of the following;  Resignation of Ms. Anand Anitha (DIN: 0240505) as Director of the Company. Details as required under Regulation 30 of the Listing Regulations and SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 as amended from time to time are given in Annexure A. Kindly take the above intimation on your records. Thanking you, Yours sincerely, For Aanjaay Industries Limited (Formerly known as Kabra Drugs Limited) Nanjappan Aravind Managing Director (Din: 01895602) Encl. Annexure A Annexure – A Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. Resignations: Sl. No. Particulars Details 1. Name of the Director Ms. Anand Anitha 2. Director Identification Number 02040505 (DIN) 3. Category / Designation Director 4. Date of Resignation 12th August 2026 5. Reason for Change viz., appointment. Due to Personal Reason 6. Disclosure of relationships between Directors Not Applicable (in case of appointment of a director). 7. Names of listed entities in which the resigning No director holds directorships, indicating the category of directorship 8. Names of listed entities in which the resigning No director holds membership of board committees, if any 9. Letter of Resignation along with detailed Letter of Resignation is attached with this reasons for resignation and Confirmation annexure. Ms. Anand Anitha has confirmed that there is no other material reasons that there is no other material reasons other other than those provided than those provided